FDA Alerts

Practice Management
Practice Management
FDA Roundup: Powdered Gloves, Opioid Warnings, Anthrax
03/22/2016
The FDA has proposed a ban on powdered medical gloves, approved new requirements for opioid warning labels, and approved a new treatment for inhalational anthrax.
03/22/2016
Vaccines
Vaccines
FDA: 2016-2017 Flu Vaccines Approved
03/07/2016
The FDA’s Vaccines and Related Biological Advisory Committee has accepted recommendations from the World Health Organization on which flu vaccines to issue next season.
03/07/2016
FDA Alerts
FDA Alerts
Bowing to pressure, FDA to reform painkiller approval process
02/05/2016
...
02/05/2016
FDA Alerts
FDA Alerts
FDA: New Hepatitis C Drug Approved
01/29/2016
The FDA has approved a new drug for the treatment of chronic hepatitis C virus genotypes 1 and 4 infection.
01/29/2016
Neurology
Neurology
FDA Approves Botox for Lower Limb Spasticity
01/22/2016
The FDA has approved new options for lower limb spasticity, relapsed multiple myeloma, and diabetic foot ulcers that healthcare professionals should be aware of.
01/22/2016
Gout
Gout
FDA: New Options for Gout, Pulmonary Arterial Hypertension
12/23/2015
The FDA has approved new options for the treatment of adults with gout and pulmonary arterial hypertension that practitioners should be aware of.
12/23/2015
FDA Alerts
FDA Alerts
U.S. FDA overturns 30-year ban on blood donations by gay men
12/22/2015
<p>The U.S. Food and Drug Administration ruled on Monday that gay men can donate blood 12 months after their last sexual contact with another man, overturning a 30-year ban aimed at preventing the...
12/22/2015
Oncology
Oncology
FDA Roundup: New Options for Lung Cancer, von Willebrand Disease
12/14/2015
The FDA approved new options for non-small cell lung cancer, von Willebrand disease, and to treat overdoses of certain chemotherapies.
12/14/2015
FDA Alert
multiple myeloma
FDA Alert
FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Heavily Pretreated Multiple Myeloma
12/10/2015
Kate Young
The FDA has granted accelerated approval to linvoseltamab-gcpt, a BCMA-directed bispecific T-cell engager, offering a new option for patients with heavily pretreated relapsed or refractory multiple myeloma....
12/10/2015
FDA Alerts
FDA Alerts
FDA Panel Recommends Tighter Regulation for Codeine
12/10/2015
A joint FDA panel has recommended new restrictions for use of codeine in children.
12/10/2015